PalmerRMFerrigeAGMoncadaS.Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327(6122):524–526.
2.
StuehrDJ.Structure-function aspects in the nitric oxide synthases. Annu Rev Pharmacol Toxicol. 1997;37:339–359.
3.
AldertonWKCooperCEKnowlesRG.Nitric oxide synthases: structure, function and inhibition. Biochem J. 2001;357(pt 3):593–615.
4.
MarsdenPAHengHHSchererSW. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthetases gene. J Biol Chem. 1993;268(23):17478–17488.
5.
FeronOBelhassenLKobzikLSmithTWKellyRAMichelT.Endothelial nitric oxide synthase targeting to caveolae: specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J Biol Chem. 1996;271(37):22810–22814.
6.
LamasSLowensteinCJMichelT.Nitric oxide signaling comes of age: 20 years and thriving. Cardiovasc Res. 2007;75(2):207–209.
7.
RahimiZNourosi-RadR.Association of Endothelial Nitric Oxide Synthase Gene Variant (G894T) with Coronary Artery Disease in Western Iran. Angiology. 2011. doi: 0003319711409741
8.
MiyamotoYSaitoYNakayamaM. Replication protein A1 reduces transcription of the endothelial nitric oxide synthase gene containing a -786T→C mutation associated with coronary spastic angina. Hum Mol Genet. 2000;9(18):2629–2637.
9.
RossiGPTaddeiSVirdisA. The T-786C and Glu298Asp polymorphisms of the endothelial nitric oxide gene affect the forearm blood flow responses of Caucasian hypertensive patients. J Am Coll Cardiol. 2003;41(6):938–945.
10.
NakayamaMYasueHYoshimuraM. T-786–>C mutation in the 5’-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation. 1999;99(22):2864–2870.
11.
KuhlencordtPJGyurkoRHanF. Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation. 2001;104(4):448–454.
12.
KolovouGAnagnostopoulouKMikhailidisDPCokkinosDV.Apolipoprotein E knockout models. Curr Pharm Des. 2008;14(4):338–351.
13.
HingoraniAD.Polymorphisms in endothelial nitric oxide synthase and atherogenesis: John French Lecture 2000. Atherosclerosis. 2001;154(3):521–527.
14.
LiJWuXLiXFengGHeLShiY.The endothelial nitric oxide synthase gene is associated with coronary artery disease: a meta-analysis. Cardiology. 2010;116(4):271–278.
15.
ArnettDKBairdAEBarkleyRA. American Heart Association Council on Epidemiology and Prevention; American Heart Association Stroke Council; Functional Genomics and Translational Biology Interdisciplinary Working Group. Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: a scientific statement from the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation. 2007;115(22):2878–2901.
16.
GlubaABanachMMikhailidisDPRyszJ.Genetic determinants of cardiovascular disease: the renin-angiotensin-aldosterone system, paraoxonases, endothelin-1, nitric oxide synthase and adrenergic receptors. In Vivo. 2009;23(5):797–812.
